To build manufacturing facilities for cancer drugs in Japan, the U.S., Germany, and China to diversify its production ...

External regulatory, economic, and technological forces ensured that the story of 2025 for CDMO marketers was turbulence. How ...

As previously announced l a st year, Fujifilm Irvine Scientific Inc. has officially changed its legal name to Fujifilm ...

Halozyme Therapeutics Inc. and Skye Bioscience Inc. have entered a non-exclusive global collaboration and license agreement.

As data volumes accelerate, AI is becoming deeply embedded in safety operations and local qualified persons for PV are ...

Evotec SE has appointed Dr. Sarah Fakih as Executive Vice President, Head of Global Communications and Investor Relations.

Emmaus has granted NeoImmuneTech Inc. an exclusive license to all rights to market, sell and distribute Endari and any ...

Hoth Therapeutics has filed two U.S. provisional patent applications that significantly expand its intellectual property ...

Harbour BioMed, a global biopharmaceutical company, has entered a long-term strategic collaboration with Yantai Lannacheng Biotechnology Co., Ltd.

Akari Therapeutics, Plc, an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, ...

Transcenta Therapeutics, a global biopharmaceutical company with capabilities in discovery, research, development and ...

CX-5461 is the first G-quadruplex (G4) stabilizer in development. It has shown promising activity in early-phase trials for breast cancer and other solid tumors in study sponsored by SU2C-CCTG in ...